ID
45967
Description
Principal Investigator: Jennifer R. Brown, Dana-Farber Cancer Institute, Broad Institute, Boston, MA, USA MeSH: Leukemia, Lymphocytic, Chronic, B-Cell https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000879 Chronic Lymphocytic Leukemia (CLL) is a hematological malignancy characterized by accumulation of CD5+CD19+ B cells in peripheral lymphoid organs, bone marrow and blood. In this study we analyze matched whole genome sequencing and RNA-seq data from CLL patients to characterize the mutational processes operative throughout tumor evolution. Source of tumor and normal DNA used is patient PBMC or B cells and saliva respectively.
Lien
Mots-clés
Versions (1)
- 26/03/2024 26/03/2024 - Madita Rudolph
Détendeur de droits
Jennifer R. Brown, Dana-Farber Cancer Institute, Broad Institute, Boston, MA, USA
Téléchargé le
26 mars 2024
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
dbGaP phs000879 DFCI Brown Lab CLL Sequencing Study
Subject ID and gender of participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- StudyEvent: SEV1
- Subject ID and consent groups of participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- Subject ID, sample ID, and sample use variable obtained from participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- Subject ID and gender of participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- Sample ID, tumor status of samples, and analyte type of samples obtained from participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
Similar models
Subject ID and gender of participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- StudyEvent: SEV1
- Subject ID and consent groups of participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- Subject ID, sample ID, and sample use variable obtained from participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- Subject ID and gender of participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.
- Sample ID, tumor status of samples, and analyte type of samples obtained from participants with or without chronic lymphocytic leukemia and involved in the "Dana-Farber Cancer Institute (DFCI) Brown Lab CLL Sequencing Study" project.